← Open Payments lookup

DAWN SHAUM: Open Payments

NPI 1164855128 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,110 in 220 payments from 17 companies in 2025. Trend: 2023 $2,439 · 2024 $3,140 · 2025 $4,110

Food & beverage: $3,999Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.24$541
Alkermes, Inc.27$525
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$443
E.R. Squibb & Sons, L.L.C.26$443
ABBVIE INC.32$332
Teva Pharmaceuticals USA, Inc.12$319
Vanda Pharmaceuticals Inc.10$239
Axsome Therapeutics, Inc.5$203
Neurocrine BioSciences, Inc.11$191
Supernus Pharmaceuticals, Inc.16$175

Products named: ARISTADA, CAPLYTA, COBENFY, REXULTI, VRAYLAR, FANAPT, ABILIFY MAINTENA, Auvelity.

Industry payments across MI — which companies pay providers there.